Similar articles for PMID: 23457159

Year	Number of Results
1996	1
1998	1
1999	1
2000	1
2001	1
2002	2
2003	1
2005	2
2006	3
2007	5
2008	5
2009	5
2010	8
2011	9
2012	4
2013	5
2014	3
2015	9
2016	6
2017	9
2018	13
2019	2
2020	8
2021	7
2022	1
2023	1
2024	0

1

Solomon JJ, Olson AL, Fischer A, Bull T, Brown KK, Raghu G. Solomon JJ, et al. Eur Respir Rev. 2013 Mar 1;22(127):6-19. doi: 10.1183/09059180.00005512. Eur Respir Rev. 2013. PMID: 23457159 Free PMC article. Review. No abstract available.

2

Progressive systemic sclerosis and the lung.

Veeraraghavan S, Sharma OP. Veeraraghavan S, et al. Curr Opin Pulm Med. 1998 Sep;4(5):305-9. doi: 10.1097/00063198-199809000-00011. Curr Opin Pulm Med. 1998. PMID: 10813207 Review.

3

Interstitial lung disease in systemic sclerosis: current and future treatment.

Giacomelli R, Liakouli V, Berardicurti O, Ruscitti P, Di Benedetto P, Carubbi F, Guggino G, Di Bartolomeo S, Ciccia F, Triolo G, Cipriani P. Giacomelli R, et al. Rheumatol Int. 2017 Jun;37(6):853-863. doi: 10.1007/s00296-016-3636-7. Epub 2017 Jan 6. Rheumatol Int. 2017. PMID: 28063071 Review.

4

Scleroderma lung disease, variation in screening, diagnosis and treatment practices between rheumatologists and respiratory physicians.

Mangat P, Conron M, Gabbay E, Proudman SM; Pulmonary Interstitial Vascular Organisational Taskforce (PIVOT). Mangat P, et al. Intern Med J. 2010 Jul;40(7):494-502. doi: 10.1111/j.1445-5994.2009.01990.x. Epub 2009 May 21. Intern Med J. 2010. PMID: 19460060

5

Survival in pulmonary hypertension associated with the scleroderma spectrum of diseases: impact of interstitial lung disease.

Mathai SC, Hummers LK, Champion HC, Wigley FM, Zaiman A, Hassoun PM, Girgis RE. Mathai SC, et al. Arthritis Rheum. 2009 Feb;60(2):569-77. doi: 10.1002/art.24267. Arthritis Rheum. 2009. PMID: 19180517 Free article.

6

Interstitial lung disease.

Cottin V. Cottin V. Eur Respir Rev. 2013 Mar 1;22(127):26-32. doi: 10.1183/09059180.00006812. Eur Respir Rev. 2013. PMID: 23457161 Free PMC article. Review.

7

Imaging lung disease in systemic sclerosis.

Strollo D, Goldin J. Strollo D, et al. Curr Rheumatol Rep. 2010 Apr;12(2):156-61. doi: 10.1007/s11926-010-0095-0. Curr Rheumatol Rep. 2010. PMID: 20425026 Free PMC article. Review.

8

Clinical characteristics and survival in systemic sclerosis-related pulmonary hypertension associated with interstitial lung disease.

Launay D, Humbert M, Berezne A, Cottin V, Allanore Y, Couderc LJ, Bletry O, Yaici A, Hatron PY, Mouthon L, Le Pavec J, Clerson P, Hachulla E. Launay D, et al. Chest. 2011 Oct;140(4):1016-1024. doi: 10.1378/chest.10-2473. Epub 2011 Apr 7. Chest. 2011. PMID: 21474572

9

Improved transplant-free survival in patients with systemic sclerosis-associated pulmonary hypertension and interstitial lung disease.

Volkmann ER, Saggar R, Khanna D, Torres B, Flora A, Yoder L, Clements PJ, Elashoff RM, Ross DJ, Agrawal H, Borazan N, Furst DE, Saggar R. Volkmann ER, et al. Arthritis Rheumatol. 2014 Jul;66(7):1900-8. doi: 10.1002/art.38623. Arthritis Rheumatol. 2014. PMID: 24729406 Free article.

10

Interstitial lung disease in systemic sclerosis: pathophysiology, current and new advances in therapy.

Jain S, Shahane A, Derk CT. Jain S, et al. Inflamm Allergy Drug Targets. 2012 Aug 1;11(4):266-77. doi: 10.2174/187152812800959013. Inflamm Allergy Drug Targets. 2012. PMID: 22506881 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

100 results

Results by year